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BACKGROUND: Restorative proctocolectomy with 
ileal pouch-anal reconstruction is the standard 
prophylactic surgical procedure for patients with familial 
adenomatous polyposis. However, several groups have 
reported the development of adenomas and even 
carcinomas within the ileal pouch. The predisposing 
factor was the time interval after pouch surgery in some 
studies, but it was the severity of the initial colonic 
disease and duodenal adenomatosis in others.
OBJECTIVE: The aim of this study was to further clarify 
the prevalence of pouch adenomas, clinical risk factors, 
and a possible phenotype–genotype relation in a large 
population of patients with familial adenomatous 
polyposis, as well as to analyze pouch adenoma-free 
survival.
DESIGN: This study was designed as a cohort study.
SETTINGS: This study was conducted in a specialized 
outpatient clinic at the University of Heidelberg.
PATIENTS: A total of 192 patients with familial adenomatous 
polyposis were included, and all of the available endoscopy 
reports after pouch surgery were screened for pouch 
adenomas. Additional clinical information was retrieved from 
the Heidelberg Polyposis Register.
MAIN OUTCOME MEASURES: This present study revealed 
3 main independent risk factors for the development of 
pouch adenomas: age <18 years at the time of IPAA, male 
sex, and the presence of gastric adenomas. Secondary 
outcome measures were adenoma progression and overall 
pouch adenoma-free survival.
RESULTS: Pouch adenomas were detected in 46.9% of 
patients. Median follow-up was 12.8 years (interquartile 
range, 9.0–17.0 y) for patients with pouch adenomas 
and 7.3 years (interquartile range, 2.5–12.2 y) for those 
without them. Patients underwent pouch surgery at 
a median age of 27.5 years (range, 10.2–58.5 y), and 
pouch adenomas occurred a median of 8.5 years (range, 
0.9–25.1 y) after surgery. Also detected were gastric 
adenomas in 37.2%, duodenal adenomas in 80.3%, and 
desmoid tumors in 24.5% of patients. Estimation of 
pouch adenoma-free survival revealed that, after 20 years, 
only ≈22% of patients would be free of pouch adenomas. 
Male sex, age ≦18 years at the time of pouch surgery, 
and gastric adenomas were found to be independent 
risk factors for the development of pouch adenomas 
in a multivariate Cox regression analysis (p = 0.0002, 
p = 0.0059, and p = 0.0020). No predisposing germline 
mutation for pouch adenoma development was detected.
LIMITATIONS: Detailed information on the initial 
preoperative findings was not fully available, and the 
study was only carried out as a single-center study.
CONCLUSIONS: A severe upper intestinal phenotype, 
male sex, and age <18 years at the time of IPAA all 
increase the risk for development of pouch adenomas. 
See Video Abstract at http://links.lww.com/DCR/A675.
KEY WORDS: Familial adenomatous polyposis; Pouch 
adenomas; Pouch surgery.
Supplemental digital content is available for this article. Direct URL 
 citations appear in the printed text, and links to the digital files are 
 provided in the HTML and PDF versions of this article on the journal’s 
Web site (www.dcrjournal.com).
Funding/Support: None reported.
Financial Disclosure: None reported.
Preliminary results were presented at the meeting of the German Society 
for General and Visceral Surgery, Berlin, Germany, March 25 to 28, 2014.
Correspondence: Petra Ganschow, M.D., Department of General, Vis-
ceral, Vascular and Transplantation Surgery, Ludwig-Maximilians Uni-
versity, Marchionini-Str 15, München 81377, Germany. E-mail: petra.
ganschow@med.uni-munechen.de
Risk Factors Associated With Pouch Adenomas in 
Patients With Familial Adenomatous Polyposis
Petra Ganschow, M.D.1 • Silke Trauth, M.D.2 • Ulf Hinz, M.Sc.2 • Anja Schaible, M.D.2 
Markus W. Büchler, M.D.2 • Martina Kadmon, M.D.3
1 Department of General, Visceral, Vascular and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany
2 Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany
3 School of Medicine, University of Augsburg, Augsburg, Germany
Dis Colon Rectum 2018; 61: 1096–1101
DOI: 10.1097/DCR.0000000000001157
© The ASCRS 2018
ORIGINAL CONTRIBUTION
Copyright © The American Society of Colon & Rectal Surgeons, Inc. Unauthorized reproduction of this article is prohibited.
DISEASES OF THE COLON & RECTUM VOLUME 61: 9 (2018) 1097
Patients with familial adenomatous polyposis (FAP) require prophylactic surgical intervention to prevent death from colorectal cancer. Colectomy followed by 
ileorectal anastomosis is the favorable therapeutic option 
for patients with FAP with little or no rectal involvement. In 
cases with rectal involvement, however, restorative procto-
colectomy followed by IPAA, which restores good function 
and quality of life, is the procedure of choice.1–3
Prophylactic removal of the colon increases the life 
expectancy of patients with FAP, but extracolonic mani-
festations consisting mainly of desmoid tumors and 
duodenal adenomas and carcinomas gain in importance 
over the course of the disease.4 Several groups have also 
suggested that adenomas and carcinomas within the ileal 
pouch represent life-limiting factors.5–10 Reported rates 
of pouch adenomas vary between 35% and 57%.5–11 Data 
on risk factors are controversial, because they are based 
mainly on small patient series. Some studies have reported 
the time interval after pouch surgery and the severity of 
the initial colonic disease manifestation or duodenal ad-
enomas to be predisposing factors, although others could 
not confirm these observations.5–10 To date, no relation be-
tween a germline mutation and pouch adenomas has been 
detected.8,9 The aim of the present study was to examine 
the prevalence and risk factors for the development of 
pouch adenomas in a large FAP patient sample. Secondary 
outcome measures were adenoma progression and overall 
pouch adenoma-free survival.
PATIENTS AND METHODS
The study was approved by the internal review board of 
the Heidelberg Medical Faculty. This study was designed 
as a cohort study. We identified 193 consecutive patients 
with FAP who had undergone pouch surgery and were fol-
lowed up at our specialized outpatient clinic between May 
2010 and August 2013. Data on follow-up were document-
ed prospectively. At the beginning of the study period, a 
new standardized documentation sheet for pouch endos-
copies was introduced (Supplemental Digital Content 1,  
http://links.lww.com/DCR/A743), which includes, among 
other details, a systematic description of pouch adenomas. 
Additional descriptive endoscopy reports were formulated 
for each pouch endoscopy.
The regular follow-up protocol included clinical ex-
aminations and yearly endoscopies of the pouch and of 
the pouch-anal anastomosis. The follow-up interval for 
upper GI endoscopies depended on the phenotype and 
was defined by the current Spigelman stage.12 In addition, 
abdominal ultrasounds and/or MRIs were performed if 
desmoid tumors were suspected and then repeated de-
pending on findings and treatment.
All of the pouch endoscopy reports from the time 
of the patient IPAA (n = 1536) were reviewed for pouch 
 adenomas and pouchitis. Likewise, all of the upper GI en-
doscopy reports were reviewed for gastric and duodenal 
adenomas. Additional clinical data, mutation analyses, 
and pathology reports were retrieved from clinical charts 
and the Heidelberg Polyposis Register. Adenomas arising 
from the remaining rectal mucosa were excluded from the 
analysis. The mean number of bowel movements per 24 
hours was calculated based on the number of bowel move-
ments at each follow-up appointment.
Led by the Spigelman classification, we defined pouch 
adenoma severity according to the number (1–4, 5–10, or 
>10 adenomas) and size (≤4, 5–10, or ≥10 mm) of the ad-
enomas.12 Progression of pouch adenomas was defined as 
an increase in the number and/or size of the adenomas, 
as well as a change in the histological pattern from tubu-
lar to villous or development of high-grade dysplasia or 
malignancy.
Statistical Analysis
SAS software (version 9.4, SAS Institute Inc, Cary, NC) was 
used for statistical analysis. The quantitative variables age 
at the time of IPAA, follow-up since IPAA, and number of 
bowel movements were expressed as the median with an 
interquartile range (IQR) or range. The nonparametric 
Mann–Whitney U test was used to compare these quanti-
tative variables between patients with and without pouch 
adenomas. Variables with a categorical score level are pre-
sented as absolute and relative frequencies. Subgroups of 
patients were analyzed using the Fisher exact test or the χ2 
test, as appropriate. Adenoma-free pouch survival was de-
fined as the time from the date of IPAA to either histologi-
cal diagnosis of pouch adenoma or last follow-up. Patients 
without pouch adenomas at the last follow-up were cen-
sored. Follow-up time was given as the median with an in-
terquartile range. Survival curves were calculated using the 
Kaplan–Meier method. The 5-, 10-, 15-, and 20-year pouch 
adenoma-free survival rates and the median survival time 
are presented. Differences in pouch adenoma-free surviv-
al between subgroups of patients were analyzed using the 
log-rank test. A multivariate Cox regression analysis was 
performed to assess the impact of variables on pouch ade-
noma-free survival. HRs with 95% CIs are given. Two-sided 
values of p < 0.05 were considered statistically significant.
RESULTS
A total of 193 patients were screened. Of those, 192 (100 
males and 92 females) were enrolled in the study. One patient 
with an MUTYH mutation was excluded from the statistical 
analysis. Among all of the participants, the median follow-up 
after pouch surgery was 10.1 years (IQR, 5.5–15.4 y) and was 
12.8 years (IQR, 9.0–17.0 y) among patients with pouch ad-
enomas and 7.3 years (IQR, 2.5–12.2 y) among those without 
pouch adenomas. The median age at the time of IPAA was 
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27.5 years (range, 10.2–58.5 y; Table 1). The median number 
of follow-up endoscopies was 8 (IQR, 5–11).
Histologically confirmed adenomas arising from the 
pouch mucosa were detected in 90 patients (46.9%) at a 
median of 8.5 years (range, 0.9–25.1 y) after IPAA. Among 
them, 46 patients (51.1%) had <4, 14 (15.6%) had 5 to 10, 
and 30 (33.3%) had >10 adenomas within the pouch. The 
maximum size of the pouch adenomas was ≤4 mm in 53 
patients (58.9%), 5 to 10 mm in 24 patients (26.7%), and 
>10 mm in 13 patients (14.4%). Tubular adenomas were de-
tected in 69 patients (76.7%), tubulovillous adenomas were 
detected in 16 patients (17.8%), and villous adenomas were 
detected in 5 patients (5.6%). Thirty-two patients (35.9%) 
showed progression of pouch adenomas during follow-up.
Upper-GI endoscopy reports were available for 183 
patients. Gastric adenomas were histologically verified 
in 68 (37.2%) of 183 patients, and duodenal adenomas 
were verified in 147 patients (80.3%). Forty-seven patients 
(24.5%) experienced desmoid tumors, whereas 36 (18.6%) 
had neither pouch adenomas nor duodenal or gastric ad-
enomas. None of the patients developed pouch adenomas 
before closure of their ileostomy. One patient developed a 
pouch carcinoma 27 years after IPAA, necessitating pouch 
extirpation and reconstruction of a new pouch.
Follow-up Interval, Age, and Sex
Age at the time of IPAA did not differ significantly between 
patients with and without pouch adenomas (p = 0.1901). 
However, the follow-up period and the duration of proper 
pouch function were significantly longer among patients 
with pouch adenomas than those without pouch adenomas 
(p < 0.0001; Table 2). In addition, significantly more male 
patients developed pouch adenomas (p = 0.0083; Table 2).
Extracolonic Manifestations
Patients with gastric (n = 68; p = 0.0004) or duodenal ad-
enomas (n = 147; p = 0.0014) developed pouch adenomas 
significantly more frequently than those without gastric or 
duodenal adenomas (Table 2). The presence of desmoid 
tumors, however, was not related to the occurrence of 
pouch adenomas (p = 0.5078; Table 2).
Number of Bowel Movements and Pouchitis
The median number of bowel movements was 6 (IQR, 
5–8) per 24 hours. The number of bowel movements per 
24 hours did not differ between patients with and without 
pouch adenomas (p = 0.9734). Histologically proven pou-
chitis persisting for >3 months was found in 31.8% of the 
patients but did not have an impact on the development of 
pouch adenomas (p = 0.6622; Table 2).
Mutation Analysis
Information on the underlying germline mutation was 
available for 66 patients (73.3%) with pouch adenomas 
and 67 patients (65.7%) without pouch adenomas. Most 
TABLE 1.   Demographic, clinical, and histological data of study 
population (N = 192)
Parameter Median (IQR) n (%)
Age at time of IPAA, y 27.5  
(10.2–58.5)
 
Sex, female:male  92:100  
(47.9:52.1)
Follow-up since IPAA, y 10.1  
(5.5–15.4)
 
No. of follow-up endoscopies 8 (5–11)  
No. of bowel movements 6 (5–8)  
Pouch adenomas  90 (46.9)
Duodenal adenomas  147 (80.3)
Gastric adenomas  68 (37.2)
Desmoid tumors  47 (24.5)
Results of quantitative and categorical variables are presented as median with 
interquartile range (IQR) unless otherwise stated and as absolute and relative 
frequencies.
TABLE 2.   Demographic data of patients with and without pouch adenomas
Total
Presence of pouch  
adenomas, N = 90 (46.9%)
Absence of pouch  
adenomas, N = 102 (53.1%) p
Age at time of IPAA, mean (SD), y 27.8 (9.4) 30.6 (11.7) 0.1901
Follow-up since IPAA, y    
  Mean with SD 13.9 (6.9) 8.1 (6.2) <0.0001a
  Median with IQR 12.8 (9.0–17.0) 7.3 (2.5–12.2)  
Sex    
  Male patients (n = 100) 56 (56.0) 44 (44.0) 0.0083a
  Female patients (n = 92) 34 (37.0) 58 (63.0)  
No. of bowel movements 6.8 (3.1) 6.8 (2.6) 0.9734
Duodenal adenomas (n = 147) of 183 patients  
with regular gastroscopies
81 (55.1) 66 (44.9) 0.0014a
Gastric adenomas (n = 68) of 183 patients  
with regular gastroscopies
45 (66.2) 23 (33.8) 0.0004a
Desmoid tumors (n = 47) 24 (51.1) 23 (48.9) 0.5078
Pouchitis (n = 61) (histological signs for >3 mo) 30 (49.2) 31 (50.8) 0.6622
IQR = interquartile range.
aP value is significant.
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patients in both groups had mutations within exon 15 of 
APC, primarily at the 5′ end of codon 1309. No difference 
in the distribution of germline mutations was found be-
tween patients with and without pouch adenomas or be-
tween male and female patients with pouch adenomas.
Pouch Adenoma-Free Survival
Kaplan–Meier estimation of pouch adenoma-free survival 
shows that, 5 years after IPAA, 84.9% of patients remain 
free of pouch adenomas. After 15 years, however, only 
40.4% remain free of pouch adenomas, and after 20 years 
only 21.9% of the patients will not have developed pouch 
adenomas (Fig. 1A). Patients who underwent IPAA at ≤18 
years of age developed pouch adenomas significantly earlier 
than those >19 years at the time of their IPAA (p = 0.0173). 
Likewise, patients with gastric adenomas (p = 0.0019) and 
males (p = 0.0017) showed pouch adenomas significantly 
earlier than others (Figs. 1B–D). Estimation of pouch ad-
enoma-free survival in patients with or without duodenal 
adenomas suggests earlier development of pouch adenomas 
in the presence of duodenal adenomas, although the cor-
relation was not significant (p = 0.1462). Multivariate Cox 
regression analysis confirmed that male sex (HR = 2.4 (95% 
CI, 1.5–3.8)), the presence of gastric adenomas (HR = 1.8 
(95% CI, 1.2–2.8)), and age at the time of IPAA ≤18 years 
(HR = 2.5 (95% CI, 1.4–4.3)) were independently associ-
ated with a significantly higher risk for developing pouch 
adenomas (p = 0.0002, p = 0.0059, and p = 0.0020).
DISCUSSION
To our knowledge, the present study includes the largest 
cohort of patients with FAP who has been screened for a 
prevalence of pouch adenomas and their underlying risk 
100




0 5 10 15
Time after IPAA (years)
20 25 30
100




0 5 10 15
Time after IPAA (years)
Age ≤18 years at IPAA
p = 0.0173













0 5 10 15
Time after IPAA (years)
20 25 30
100




0 5 10 15




FIGURE 1. A, Kaplan–Meier curve showing overall pouch adenoma-free survival. B, Kaplan–Meier curves comparing pouch adenoma-free survival 
between patients ≤18 and ≥19 years of age at the time of IPAA. C, Kaplan–Meier curves comparing pouch adenoma-free survival between patients 
with and without gastric adenomas. D, Kaplan–Meier curves comparing pouch adenoma-free survival between male and female patients.
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factors during follow-up after IPAA. Given that nearly 
half of the study participants developed pouch adenomas 
during the follow-up period, we would anticipate that 
only ≈22% of patients would be free of pouch adenomas 
20 years after surgery. Pouch adenomas thus appear to 
represent a highly relevant risk for patients with FAP. The 
prevalence of pouch adenomas in the present study is 
consistent with earlier reported pouch adenoma rates in 
smaller FAP populations.6–9
This present study revealed 3 main independent risk 
factors for the development of pouch adenomas: age 
<18 years at the time of IPAA, male sex, and the presence 
of gastric adenomas. Although young age at the time of 
surgery had been reported previously to be a risk fac-
tor, male sex and the presence of gastric adenomas had 
not been identified as predictors for the development of 
pouch adenomas.9 In addition, we have confirmed that the 
postoperative interval after IPAA is a relevant risk factor 
for the development of pouch adenomas.5,7–9 Consistent 
with the findings of Parc et al,9 the presence of duodenal 
adenomas was also associated with a higher probability 
for pouch adenoma development in our series of patients 
with FAP. Thus, male sex and a severe GI phenotype with 
a relatively early disease onset are associated with a higher 
risk of pouch adenoma development. In line with earlier 
studies, we detected no association between pouch adeno-
mas and the underlying germline mutation for either the 
whole population or among affected males and females.6,9 
However, mutation analysis was not available for all of the 
patients, which certainly limits the strength of this finding.
Our Kaplan–Meier estimation of pouch adenoma-
free survival over time raises concerns. Although 5 years 
after IPAA ≈85% of patients were free of pouch adenomas, 
this proportion is expected to decline to barely 22% within 
20 years after IPAA. These findings are consistent with the 
estimated 72% risk of pouch adenoma development after 
20 years reported by Tajika et al5 and the 75% risk after 15 
years reported by Parc et al.9 This implies that a number 
of adenoma-free patients in the present study will likely 
be affected by pouch adenomas in the future. Considering 
that most patients are treated surgically in their third de-
cade of life and that the ileal pouch will likely be function-
ing for >20 years, the vast majority of patients with FAP 
will develop pouch adenomas with the possible potential 
for malignant transformation. This means that close sur-
veillance of the pouch is mandatory, and new guidelines 
for the management of pouch adenomas are essential. 
Moreover, in cases where rectal involvement is absent or 
only mild, colectomy with ileorectal anastomosis should 
be considered to prolong the interval until pouch surgery 
becomes inevitable.
Groves et al8 suggested an algorithm for the manage-
ment of pouch adenomas. They recommended endoscopic 
resection in cases of moderate dysplasia or villous archi-
tecture. The feasibility and effectiveness of  endoscopic 
resection of pouch adenomas should be thoroughly eval-
uated, especially in patients at high risk, as identified in 
the present study. In cases where the safety of endoscopic 
surveillance is reduced by severe pouch adenomatosis, 
prophylactic pouch removal to avoid malignant transfor-
mation must be discussed, possibly with the chance of new 
pouch reconstruction.
Based on our present findings, we recommend use 
of a standardized follow-up protocol and documenta-
tion to reduce interphysician differences. Pouch endos-
copy should be performed on a yearly basis and include 
standardized biopsies if pouch adenomas are observed. In 
the case of small adenomas, they should be histologically 
confirmed and followed up, depending on their size. For 
adenomas >5 mm, we recommend endoscopic removal. If 
a single high-grade dysplasia is diagnosed, an endoscopic 
mucosectomy should be performed, if possible. In cases 
with multiple adenomas causing a difficult surveillance 
situation or detection of high-grade dysplasia, pouch re-
moval and possible reconstruction must be discussed.
CONCLUSION
Pouch adenomas affect the vast majority of patients with 
FAP after IPAA. A severe upper intestinal phenotype, male 
sex, and age <18 years at the time of IPAA all increase the 
risk of developing pouch adenomas. Thorough endoscopic 
surveillance of the pouch is mandatory for patients with 
FAP, even more so if they carry the aforementioned risk 
factors. Guidelines for the management of pouch adeno-
matosis are needed, including an algorithm with thera-
peutic options taking into consideration pouch adenoma 
severity.
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